TACLOBAN CITY – Eastern Samar Governor Ben Evardone has made a request before the National Task Force against Covid-19 for the increase of vaccine allocation to the province.
In his letter, addressed to Chief Implementer Secretary Carlito Galvez Jr., and Deputy Chief Implementer Secretary Vivencio Dizon, Evardone said that the increase of vaccine allocation in the province will allow them to maximize the potential of their vaccination centers in all municipalities and to inoculate as much of the eligible population.
“Eastern Samar, much like its neighboring provinces in Region VIII, is into its 3rd wave of the COVID-19 surge which started on May 18, 2021,” the governor said.
“As of today, we have 1, 808 confirmed cases, 224 of which are active cases. We have officially surpassed the peak of our second wave last year and this surge is now the worst we have since the start of the pandemic,” the governor added in the letter dated June 21.
As of June 23, Eastern Samar has now a total of 1, 831 confirmed COVID-19 cases, of which a total of 223 active cases, with 52 deaths.
Majority of the confirmed cases are from Guiuan town with 444, and Borongan City, the capital of Eastern Samar, with 359.
The governor said that despite the limited vaccine allocation, the provincial government is proud that Eastern Samar has one of the highest vaccine utilization rates in our region.
However, the limited supply has allowed us to inoculate only 59 percent of our A.1, 21 percent of A.2, and 33 percent of A.3.
“With this, it is unfortunate that the operations of our vaccination centers are not maximized and are only being used on the average of 2-3 times a week,” Evardone said.
“If granted this request, we are positive that the number of people vaccinated in our A.1, A.2, A.3 categories will increase and the operation of our vaccination centers will be maximized,” he added.
Based on the data from the Provincial Health Office of Eastern Samar, the province had vaccinated a total of 26, 995 individuals for the 1st dose while, 14, 399 were inoculated for the second dose.
Of the inoculated with COVID-19 vaccines, 13 have experienced mild adverse events which includes hypertension, dizziness, headache, and hypertension. (ROEL T. AMAZONA)